Leafly

SEPTEMBER 15, 2020

In order for a prescription drug to reach the market, it must be extensively studied, first in animal and then in human clinical trials. Safety, efficacy, and risks must be determined. But as anyone who has seen a commercial for a prescription drug knows, there are still side effects. There are risks in stopping a […].

Clinical Trials 145

Clinical Trials Safety Cannabis 145

Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Extensive early phase experience with appropriate safety oversight and early phase clinic.

Clinical Trials 75

Clinical Trials Research and Development Hybrid Medicine 75

Cannabis Law Report

JANUARY 11, 2023

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

Clinical Trials 52

Clinical Trials CBD Sleep Pharmaceutical 52

Cannabis Law Report

AUGUST 23, 2021

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. Here’s the mindless blurb.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

The Cannigma

OCTOBER 11, 2021

No clinical trial was used in the compilation of the study. The researchers themselves wrote that the study is the first “to document self-reported efficacy of CBG-predominant products,” and provides further indication that “CBG-predominant cannabis-based medicines should be studied in randomized controlled trials.”.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Unlike competitors administering generic psychedelics, the company’s patented technology could improve safety and efficacy while guaranteeing market exclusivity. Silo Pharma Inc. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Veriheal

JANUARY 11, 2023

Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. How do you feel about this being the largest cannabis impairment clinical trial ever? Here’s what he had to say.

Clinical Trials 98

Clinical Trials THC Data Safety 98

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic.

Clinical Trials 116

Clinical Trials Chronic Pain Hydroponic Strains 116

Medical Marijuana Program Connection

FEBRUARY 28, 2023

Incannex Healthcare Limited IXHL IHL has commenced a phase 2 clinical trial to assess the safety and efficacy of its. Read More

Clinical Trials 40

Clinical Trials Treatment Safety CBD 40

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Project CBD

JANUARY 31, 2023

A 2018 report by the World Health Organization concluded that CBD “is generally well-tolerated with a good safety profile [and] exhibits no effects indicative of any abuse or dependence potential.” A clinical trial by ValidCare assessing CBD’s impact on human liver function has given the compound a clean bill of health.

CBD 130

CBD Clinical Trials Pharmaceutical Food 130

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JULY 28, 2021

This includes First Time in Human (“FTiH”) clinical trials, which are expected to commence in 2022, for the Group’s lead compound OCT461201, a selective cannabinoid receptor type 2 (“CB2”) agonist with initial indications in the areas of post herpetic neuralgia and visceral pain caused by irritable bowel syndrome.

Cannabinoids 81

Cannabinoids Clinical Trials Safety Medicine 81

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

LifeCannMD

JULY 3, 2024

Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms. While preliminary research and anecdotal evidence are promising, more rigorous clinical trials are needed to establish standardized treatment protocols and ensure safety.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

Veriheal

JUNE 29, 2022

Psilocybin , a psychedelic compound found in a variety of mushrooms, has long been used as a tool to mitigate depression despite the limited amount of research on its efficacy and safety. While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

The Cannigma

MARCH 7, 2022

What can the current clinical trials tell us? A common theme with cannabis is that more research is needed, so thankfully there are clinical trials in the works looking at the therapeutic utility of CBN.

THC 139

THC Sleep Clinical Trials Cannabinoids 139

Cannabis Law Report

AUGUST 3, 2021

Vigorous scientific research and clinical trials are needed. Cybin has not conducted clinical trials for the use of its proposed products. Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

Clinical Trials 105

Clinical Trials Events Treatment Banking 105

Cannabis Law Report

OCTOBER 6, 2021

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

Cannabis Law Report

AUGUST 5, 2021

Thanks to the license, Filament will look to create the first-ever natural pharmaceutical grade extracts and put them into clinical trials in order to demonstrate safety and efficacy. In a previous press release , Filament Health said the amended license “increases the scope” of its work with natural psychedelics.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

NORML

JANUARY 4, 2019

Separate provisions in the bill exclude cannabidiol from the federal definition of marijuana, permit VA doctors to authorize medical cannabis access to qualified patients, and remove undue federal barriers to clinical trial research to better assess the safety and efficacy of medical cannabis.

Legislation 127

Legislation Clinical Trials Research and Development Access 127

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

AUGUST 22, 2021

PsyBio intends to continue utilizing its resources to rapidly develop and test new drug candidates within this and other psychedelic categories in anticipation of launching future clinical trials. ” About PsyBio Therapeutics Corp. . ” About PsyBio Therapeutics Corp.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Cannabis Law Report

JUNE 21, 2021

Taking the doctor-patient use of RYAH devices one step further, organizations conducting clinical trials are finding value in the company’s offerings. RYAH Smart inhalers are being used in a huge clinical trial based in the UK. Over a five year study, the clinic intends to work with tens of thousands of patients.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc.,

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Veriheal

AUGUST 28, 2023

And it further reinforces the need to carry out clinical trials to determine the safety and efficiency of using psilocybin to treat OCD. ” Simply put, there is the expectation that ongoing and future clinical trials will further establish therapeutic potential in using psilocybin for OCD.

Treatment 78

Treatment Clinical Trials Therapy Research and Development 78

MMJ Recs

JULY 30, 2024

Advocates call for expanded research initiatives, including large-scale clinical trials with standardized protocols and investigations into specific cannabinoid formulations and delivery methods. While early research is promising, more rigorous studies are needed to establish efficacy, safety, and optimal dosing strategies.

Therapy 116

Therapy Treatment Clinical Trials Sleep 116

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. Danielle Schlosser PhD appointed Senior Vice-President, Clinical Innovation, to lead therapist research and training, bringing her clinical experience in behavioural health and expertise in digital health innovation. Business highlights.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

The Blunt Truth

DECEMBER 23, 2020

assured, “The FDA’s first priority is to protect the health and safety of Americans. In its announcement of the warning letters, FDA Principal Deputy Commissioner Amy Abernethy, M.D., Actions Speak Louder Than Words.

CBD 103

CBD Food Safety Clinical Trials 103

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

The Cannigma

FEBRUARY 2, 2021

million clinical trial investigating the effects of CBD on hallucinations and delusions related to the disease. With such a mixed body of scientific literature, it is particularly striking that more than 50% of cannabis users in this survey reported noticeable clinical benefits, as well as generally very good tolerability. “It

Patients 87

Patients Clinical Trials Research and Development Treatment 87

WeedAdvisor

JULY 4, 2019

It could be argued that the DEA is hesitant for the sake of public safety. Frustrated with the DEA’s obvious dodging that will likely go on indefinitely, the researchers decided to take legal action in hopes of expediting the process. However, it is much more likely that they are too proud to risk being inevitably proven wrong.

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. – Phase 2 Trial Underway. Additionally, this novel antibody conjugate demonstrated very good tolerability during this DLT phase 1 trial. Clinical trial information: NCT03276572 ( [link] ). Abstract Number: 5015.

Data 100

Data Research and Development Clinical Trials Therapy 100

Cannabis Law Report

AUGUST 21, 2019

However, health professionals have been reluctant to prescribe cannabis-based medicines in the UK because of the lack of clinical trial evidence of its benefits and safety. This would answer questions about safety and efficacy, they said. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81